DRUTIVIN

This brand name is authorized in Nigeria.

Active ingredients

The drug DRUTIVIN contains one active pharmaceutical ingredient (API):

1	Xylometazoline UNII X5S84033NZ - XYLOMETAZOLINE HYDROCHLORIDE
	Xylometazoline acts directly on α-adrenoreceptors but does not act on β-receptors. When used topically as a nasal decongestant, xylometazoline acts rapidly and provides long-lasting relief. Onset of action is within minutes, the decongestant effect being prolonged and lasting for up to 10 hours.
	Read more about Xylometazoline

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-5095	Nasal drops	DRUTIVIN NASAL DROP SOL_DROPS 0.05% 10ml	4 RNW-PP-330093 DRUTIVIN NASAL DROP XYLOMETAZOLINE HYDROCHLORIDE XYLOMETAZOLINE HCL 0.200KG, SODIUM CHLORIDE 0.442KG, SODIUM CITRATE 10.297KG, DISODIUM EDETATE 0.198KG, HYDROCHLORIC ACID 1.ON 5.941KG, BENZALKONIUM CHLORIDE 95% 0.021KG, WATER FOR INJECTION TO 200.00LTS Apr-95 Drugs Nigerian Products 10ML OTC 4/28/2023 DRUGFIELD PHARMACEUTICALS LIMITED., LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESSWAY, SANGO-OTA,OGUN STATE 8029055002 info@drugfieldpharma.com DRUGFIELD PHARMACEUTICALS LIMITED, 48, AKEJU STREET, PALMGROVE, SOMOLU, LAGOS STATE. P.O BOX 5831, IKEJA, LAGOS STATE., Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01AA07	Xylometazoline	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AA Sympathomimetics, plain
Discover more medicines within R01AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-5095